Catheter Precision, Inc. (VTAK)
USD 0.27
(0.33%)
USD 0.27
(0.33%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -15.11 Million USD | 351.84% |
| 2022 | -22.36 Million USD | 37.83% |
| 2021 | -27.7 Million USD | 18.84% |
| 2020 | -33.3 Million USD | 37.54% |
| 2019 | -54.94 Million USD | -85.27% |
| 2018 | -30.18 Million USD | -77.63% |
| 2017 | -17.54 Million USD | -327.54% |
| 2016 | -4.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.09 Million USD | -0.67% |
| 2024 Q2 | -2.2 Million USD | -29.75% |
| 2023 Q2 | 3.38 Million USD | -92.81% |
| 2023 Q1 | 47.13 Million USD | 690.33% |
| 2023 FY | - USD | 351.84% |
| 2023 Q4 | -2.08 Million USD | 5.88% |
| 2023 Q3 | -2.21 Million USD | -165.23% |
| 2022 Q1 | -5.31 Million USD | 35.66% |
| 2022 FY | - USD | 37.83% |
| 2022 Q4 | -7.98 Million USD | -120.25% |
| 2022 Q3 | -3.62 Million USD | -185.43% |
| 2022 Q2 | -1.27 Million USD | 76.11% |
| 2021 Q2 | -6.81 Million USD | -1.28% |
| 2021 Q4 | -8.26 Million USD | -17.64% |
| 2021 FY | - USD | 18.84% |
| 2021 Q3 | -7.02 Million USD | -3.08% |
| 2021 Q1 | -6.72 Million USD | 35.2% |
| 2020 FY | - USD | 37.54% |
| 2020 Q2 | -9.47 Million USD | -21.57% |
| 2020 Q4 | -10.38 Million USD | -33.66% |
| 2020 Q3 | -7.76 Million USD | 17.96% |
| 2020 Q1 | -7.79 Million USD | 20.83% |
| 2019 Q3 | -16.88 Million USD | -15.61% |
| 2019 Q2 | -14.6 Million USD | 2.34% |
| 2019 Q1 | -14.95 Million USD | 2.07% |
| 2019 FY | - USD | -85.27% |
| 2019 Q4 | -9.84 Million USD | 41.72% |
| 2018 Q2 | -8.25 Million USD | -218.03% |
| 2018 FY | - USD | -77.63% |
| 2018 Q4 | -15.27 Million USD | -228.46% |
| 2018 Q1 | -2.59 Million USD | 14.15% |
| 2018 Q3 | -4.64 Million USD | 43.69% |
| 2017 Q4 | -3.02 Million USD | -82.39% |
| 2017 Q2 | -11.22 Million USD | -589.32% |
| 2017 Q1 | -1.62 Million USD | 0.0% |
| 2017 Q3 | -1.65 Million USD | 85.23% |
| 2017 FY | - USD | -327.54% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | -14.83 Million USD | -1.833% |
| Electromed, Inc. | 7.42 Million USD | 303.584% |
| Senseonics Holdings, Inc. | -48 Million USD | 68.524% |
| Xtant Medical Holdings, Inc. | -6.98 Million USD | -116.352% |